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Lymphocytic choriomeningitis virus (LCMV) Armstrong strain selectively and persistently infects the majority of growth
hormone (GH) producing cells in the anterior lobe of pituitary glands of C3H/St mice but negligibly infects GH producing cells
of BALB/WEHI mice (Oldstone et al., Virology 142, 175–182, 1985; Oldstone et al., Science 218, 1125–1127, 1982). Although
infected GH cells remain free of structural damage, disrupted initiation of GH transcription (Klavinskis and Oldstone, J. Gen.
Virol. 68, 1867–1873, 1989; Valsamakis et al., Virology 156, 214–220, 1987) occurs with a resultant decrease in the synthesis
of GH, leading to a failure of growth and development (Oldstone et al., Science 218, 1125–1127, 1982). Microsatellite mapping
of DNA obtained from 101 individual C3H/St 3 BALB/WEHI F1 3 F1 mice shows that the growth failure correlates with host
genes linked (P value 0.0008) on chromosome 17 just outside of the H-2D MHC site between D17 Mit24 and D17 Mit51, a
distance of 2.5 cM. The genetic mapping done here excludes alpha-dystroglycan (a-DG), a known receptor for LCMV (Cao
et al., Science 282, 2079–2081, 1998) in pathogenesis of GH disease, as a-DG is encoded in the mouse by a gene residing
on chromosome 9 (Yotsumoto et al., Hum. Mol. Genet. 5, 1259–1267, 1996). © 2001 Academic Press
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Virus infection can alter the differentiation (luxury)
function of a cell without destroying its vital function (de
la Torre and Oldstone, 1996; Oldstone, 1989, 1993). That
is, persistent virus infection disrupts the synthesis of a
critical product made by an infected cell without injuring
or lysing that cell. The loss of cell function then can tip
the balance of homeostasis and cause clinical disease.
For example, in vivo infection of growth hormone (GH)
roducing cells has led to GH deficiency (Klavinskis and
ldstone, 1989; Oldstone et al., 1985, 1984a, 1982; Teng
t al., 1996; Valsamakis et al., 1987), infection of thyro-
globulin producing cells led to T3 and T4 deficiency
(Klavinskis and Oldstone, 1987), infection of islet cells led
to chemical diabetes (Oldstone et al., 1984b; Rayfield et
al., 1981), and infection of neuronal cells led to neural
transmitter defects (Barrett et al., 1986; Lipkin et al.,
1988), disorders in cognitive function (Brot et al., 1997; de
la Torre et al., 1996), or disorders in neuronal integration
ctivity (Gourmelon et al., 1986). Of these examples, the
est studied to date has been lymphocytic choriomenin-
itis virus (LCMV) infection of GH producing cells.
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61The LCMV genome consists of two RNA segments, a
hort (S) and long (L) RNA. The S RNA encodes the viral
lycoprotein (GP) and nucleoprotein (NP), while the L
NA encodes the viral polymerase (L) and a small pro-
ein, Z, which regulates replication and transcription (Lee
t al., 2000; Riviere et al., 1985b; Salvato et al., 1989, 1988;
Salvato and Shimomaye, 1989). By using reassortants
between a LCMV strain that causes GH disease (LCMV
ARM) and one that does not (LCMV WE), the viral genes
causing GH disease were mapped to the S RNA (Riviere
et al., 1985a). Isolating, sequencing, and making reas-
sortants between WE virus clones that caused or did not
cause GH disease mapped the viral genetic basis of this
phenotypic difference to a single amino acid (aa) muta-
tion, aa 153 (GH disease1 WE: Ser to GH disease2 WE
he) (Teng et al., 1996) in the LCMV GP, the molecule
nvolved in binding to the viral receptor (Borrow and
ldstone, 1992; Cao et al., 1998; Sevilla et al., 2000).
Hence, differences in expression of the LCMV receptor,
alpha-dystroglycan (a-DG), between C3H/St (GH1 dis-
ase) and BALB (GH2 disease) on the GH cells in the
ituitary or of a coreceptor might explain, in part, the
isease pathogenesis.
In addition to the viral GP, the viral NP was also
mplicated in causing GH disease. Transgenic mice ex-
ressing the LCMV NP in GH producing cells by use of
0042-6822/01 $35.00
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62 BUREAU ET AL.the GH promoter showed a failure to grow.2 Other in vivo
observations revealed that the virus’ effect was at the
initiation of transcription and other genes, like prolactin,
in the anterior lobe of the pituitary were not affected by
the virus infection (Klavinskis and Oldstone, 1989; Valsa-
makis et al., 1987). These observations were solidified
and extended by in vitro studies of GH promoter–chlor-
mphenicol acetyltransferase transfected cells and GH
romoter deletion mutants which indicated that the viral
ffect was at the level of GH promoter and due to inter-
erence with GH transactivator factor GHF1 (Pit1) (de la
orre and Oldstone, 1992). Transfection studies with the
enes encoded by the S RNA of LCMV Armstrong strain
ARM) indicated that the viral NP was responsible for
nterfering with GH transcription. Thus, in vivo and in vitro
studies implicated the viral GP for binding and entry into
the GH producing cell and the viral NP for affecting the
initiation of GH transcription.
In contrast to the data available for the role of LCMV
genes in causing the GH syndrome, less information is
available concerning host genes. C3H/St, BALB/WEHI
(BALB/W), and SWR/J mice infected at birth with LCMV
ARM harbor equivalent amounts of virus in their blood,
brain, heart, kidneys, liver, spleen, and thymus through-
out life, but only C3H/St mice replicate high titers of virus
in their anterior pituitary glands, infecting the majority of
GH producing cells (.90%), and develop GH deficiency
(Oldstone et al., 1985; Tishon and Oldstone, 1990). Adop-
tive transfer of cells producing GH corrects the growth
deficiency of such infected C3H/St mice (Oldstone et al.,
1984a). One-half of the F1 hybrid offspring produced by
crossing the susceptible C3H/St GH-deficient strain with
the BALB/W GH-resistant mice develop the disease, but
the trait is not sex-linked (Tishon and Oldstone, 1990). F1
hybrid backcrosses to the susceptible C3H/St parental
strain or to the resistant BALB/W parental strain indi-
cated the involvement of more than two genes. C3H/St
are H-2k mice and, while some other H-2k strains also
developed GH disease with LCMV infection, other H-2k
mice did not (Tishon and Oldstone, 1990). Further,
C3H/Sw mice that have the H-2b haplotype on the C3H
background developed disease, further indicating that
the disease was not related to the H-2k haplotype but to
3H background genes. Collectively, these data sug-
ested that the GH deficiency disease induced by LCMV
RM in C3H/St mice is not linked to the mouse MHC
aplotype, is not sex-linked, and is not due to a dominant
ene. Rather, multiple genes are involved and these are
elated to the C3H background (Tishon and Oldstone,
990).
In order to better define the host genes involved in the
H deficiency syndrome, we utilized microsatellite map-
ing across the mouse genome to seek areas of signif-2 de la Torre and Oldstone, unpublished observations.cant linkage between the clinical findings of growth
eficiency induced by the viral infection and genes from
01 individual susceptible C3H/St 3 resistant BALB/W
F1 mice crossed to similar F1 mice. Here we show that
the failure of GH deficiency syndrome during persistent
LCMV ARM infection maps to a region on chromosome
17 just outside the MHC H-2D site between D17 Mit24
and D17 Mit51. These data link a genetic region on
chromosome 17 which encodes genes likely involved in
the pathogenesis of GH disease induced by LCMV in-
fection.
RESULTS AND DISCUSSION
Analysis of GH deficiency syndrome in C3H/St and
BALB/W mice inoculated with LCMV ARM
In the first series of studies we checked the suscep-
tibility of C3H/St mice and resistance of BALB/W mice to
developing the GH syndrome after infection with LCMV
ARM. As shown in Fig. 1, the anterior lobe of the pituitary
gland from a susceptible C3H/St mouse expressed
LCMV NP antigens in the majority (.95%) of cells, while
FIG. 1. Expression of viral NP in cells of the anterior pituitary gland,
weights, pituitary growth hormone, and serum glucose levels in 15-day-
old C3H/St and BALB/W mice infected since birth with LCMV ARM.
LCMV NP antigen was detected with monoclonal antibody 113 to LCMV
NP and FITC fluorochrome probe. The data for 10 individual infected
C3H/St (h) and BALB/W (n ) mice are given. See Materials and Meth-
ods for assays used to immunochemically stain the pituitary gland and
quantitate GH and glucose levels.no such cells expressed LCMV NP antigens in the pitu-
itary from the resistant BALB/W mouse. Analysis of three
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63DISRUPTION OF DIFFERENTIATED FUNCTIONS IN VIRAL INFECTION, Vother mice from each group indicated that in the other
C3H/St mice, greater than 85% of cells in the anterior
pituitary lobe contained viral antigens while, in contrast,
for the other three BALB/W mice studied, none showed
greater than 15% of similar cells expressing viral deter-
minants. Use of double immunofluorescence staining
with antibodies to mouse GH–FITC and antibodies to
LCMV NP–rhodamine confirmed (Oldstone et al., 1985,
982) that the virus was replicating in cells producing
H. Figure 1 also shows clinical and chemical evidence
hat C3H/St mice infected with virus failed to grow (lower
ody weight) and had lower levels of both GH in their
ituitaries and glucose in their sera. The tightest pheno-
ype occurred when weights were compared between
3H/St and BALB/W mice. Of the 10 C3H/St mice sacri-
iced at 15 days postinoculation, weights were 4.5 g 6 1
E of 0.2 (range 5.6 to 3.8 g) for C3H/St mice compared
o 7.5 g 6 0.3 (range 9 to 6.2 g) for BALBs. In contrast,
catter was observed for GH pituitary levels (susceptible
3H/St mice, range of 26 to 2.5 mg GH/mg pituitary,
mean of 13.7 6 2.7; resistant BALB/W mice, range of 28
to 12 mg GH/mg pituitary, mean of 22 6 1.8) and for blood
glucose (susceptible C3H/St mice, range of 110 to 2
mg/dl, mean blood glucose of 47 6 10; compared to
resistant BALB/W mice, whose blood glucose levels
ranged from 178 to 90, mean 137 6 10), although P
alues were ,0.005 between each group when compar-
ng weight, GH levels in the pituitary, or blood glucose
easurements. Similar results for weights, GH, and glu-
ose had been observed in earlier experiments (Old-
tone et al., 1985, 1984a, 1982; Tishon and Oldstone,
990). Despite the differences in expression of viral an-
igen in the GH producing cells of the anterior pituitary
nd differences in growth, glucose, and GH pituitary
evels between C3H/St and BALB/W mice, virus titers in
lood and spleen were equivalent at 7 and 14 days
ostinfection (data not shown). These data suggested
hat the best correlation to use with microsatellite ge-
etic mapping would likely be with weight and not with
H or glucose measurements in F1 3 F1 (F2) mice.
elationship of weight (g) and GH levels (mg/0.5 ml
ituitary homogenate) in F2 mice
Next we inoculated F2 mice at birth with LCMV ARM.
igure 2 displays the results for weights and GH pituitary
evels in each mouse at the time of sacrifice. The P value
for correlating the heaviest mice (weight) with the high-
est GH level and the lightest mice with the lowest GH
level was significant at a P value of , 0.0001. DNA
obtained from each mouse was then subjected to mic-
rosatellite mapping across the mouse genome and the
data correlated with failure to grow or pituitary GH or
blood glucose levels.Mapping loci linked to weight variations
The DNA obtained from 101 F2 animals for which
weight had been determined 11 days postinoculation
was used to screen the entire genome with 88 polymor-
phic microsatellite markers. Between 2 and 12 loci were
analyzed for each chromosome, depending on its size.
Particular attention was taken to choose the most telo-
meric and centromeric polymorphic markers among the
microsatellites (Dietrich et al., 1992). The distance be-
tween adjacent loci varied between 1 and 33.5 cM. The
means of the weight of mice heterozygous or homozy-
gous at each locus were compared by analysis of vari-
ance (Table 1). The differences were considered statis-
tically significant when the probability of observing these
differences by chance was ,0.0016, which is equivalent
to a LOD score .2.8. This level of significance was
chosen according to the criteria proposed by Lander and
Kruglyak (1995) and corresponds to a “suggestive link-
age” because such an event is expected to occur once
by chance in a genome scan of a F2 cross. Two closely
spaced markers on chromosome 17 were significantly
associated with weight: D17Mit24 (P , 0.0007) and
D17Mit51 (P 5 0.0005) (Table 1). The effect of the
D17Mit51 locus accounted for 14.3% of the total variance.
The data were analyzed more precisely with the Map-
maker/QTL program, which showed linkage in this re-
gion as a sharp peak between the H-2 locus and the
D17Mit10 marker (Fig. 3). The most probable position of
a locus controlling the weight of the animals is close to
the D17Mit24 locus (LOD score 5 3.6). Hence, a position
on chromosome 17 barely outside of the H-2D MHC site
between D17Mit24 and D17Mit51 contains host genes
linked to susceptibility of LCMV-induced GH disease.
The distance from H-2D to D17Mit24 is 1.3 cM and that
from D17Mit24 to D17Mit51 is 2.5 cM. A few genetic loci
located within this 2.5-cM area have been mapped to
resistance/susceptibility of other microbes, i.e., Trypano-
soma (Tir1) and Leishmania (Lmr1) (Kemp et al., 1997;
Roberts et al., 1997). We are currently assessing the
FIG. 2. The values of GH and weight for individual F2 mouse whose
DNA was used for microsatellite mapping are displayed.potential role of other genes in this region for their effect
on the pathogenesis of GH disease.
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64 BUREAU ET AL.Earlier studies indicated a role for the LCMV GP1
ligand residue aa 153 (Teng et al., 1996) in GH disease.
Recently, LCMV GP aa 153 has been identified as an
important residue in binding to the LCMV receptor mol-
ecule a-DG (Sevilla et al., 2000; Smelt et al., 2000). In toto,
hese findings suggested that expression of a-DG alone
or with a coreceptor might be differentially expressed by
GH cells from C3H/St mice compared to BALB mice.
However, this does not appear likely as (1) a-DG is
encoded by a gene on mouse chromosome 9, while
susceptibility to GH disease reported here maps to
genes on chromosome 17; (2) LCMV strains ARM and
E-350 and WE variants 2.2 and 2.5 that cause GH dis-
ease bind at low affinity (ARM, E-350, WE 2.2, and 2.5:
.400 nM of soluble a-DG needed to block binding of
CMV to a-DG cells) to a-DG, while WE-wt or WE Clone
54 and Traub LCMV strains bind at high affinity to a-DG
,10 nM needed for inhibition of binding) (Sevilla et al.,
000; Smelt et al., 2000) and do not cause GH disease
Oldstone et al., 1985; Teng et al., 1996). Thus, perhaps a
novel alternative LCMV receptor occurs, is encoded by a
T
Association o
Locus name
Position
(cM) BALB/c
D17Mit113 6.5 6.1 6 0.2 (31)
D17Mit81 15.4 6.2 6 0.2 (31)
D17Mit16 16.6 6.2 6 0.2 (31)
D17Mit24 18.2 6.4 6 0.1 (30)
D17Mit51 19.4 6.4 6 0.1 (30)
D17Mit10 28.4 6.4 6 0.2 (22)
D17Mit68 28.8 6.4 6 0.2 (23)
D17Mit119 49.0 6.3 6 0.1 (30)
D17Mit93 58.3 6.2 6 0.1 (28)
D17Mit220 62.9 6.2 6 0.2 (25)
D17Mit76 69.2 6.2 6 0.1 (28)
Note. NS, not significant.FIG. 3. Linkage plot analyzed for LOD scoregene(s) on chromosome 17, and is preferentially ex-
pressed on C3H/St and other selected mouse strains
that are susceptible to GH disease (Tishon and Old-
stone, 1990). In addition, since once inside the GH pro-
ducing cell the viral NP prevents the initiation of GH
transcription by interaction with Pit-1 transcription factor
(de la Torre and Oldstone, 1992; Valsamakis et al., 1987;
de la Torre and Oldstone, unpublished data, 2000), it is
likely that genes encoded at this region on chromosome
17 may also play a role in the control of GH transcription
and its altered expression during LCMV infection.
MATERIALS AND METHODS
Mice
C3H/St, BALB/W, C3H/St 3 BALB/W F1 mice were
obtained from the vivarium of The Scripps Research
Institute (TSRI). Mice generated by crossing F1 3 F1
breeders were inoculated within the first 18 h of life with
1000 PFU of LCMV ARM 53b contained in 30l diluent
(Oldstone et al., 1985, 1984a, 1982; Teng et al., 1996;
with Weight
Weight (n)
Pheterozygote C3H
6.1 6 0.1 (49) 5.6 6 0.2 (20) NS
6.0 6 0.1 (51) 5.5 6 0.2 (19) 0.0170
6.0 6 0.1 (51) 5.5 6 0.2 (18) 0.0106
5.9 6 0.1 (51) 5.5 6 0.2 (18) 0.0007
5.9 6 0.1 (52) 5.6 6 0.2 (19) 0.0005
5.9 6 0.1 (50) 5.7 6 0.1 (28) 0.0149
5.9 6 0.1 (49) 5.7 6 0.1 (28) 0.0127
5.9 6 0.1 (42) 5.7 6 0.2 (28) 0.0391
5.9 6 0.1 (44) 5.8 6 0.2 (29) NS
6.0 6 0.1 (46) 5.6 6 0.1 (26) 0.0114
6.0 6 0.1 (46) 5.7 6 0.2 (25) 0.0824ABLE 1
f Lociusing the Mapmaker/QTL program.
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65DISRUPTION OF DIFFERENTIATED FUNCTIONS IN VIRAL INFECTION, VTishon and Oldstone, 1990). Mice were examined clini-
cally every day, with body weight measured at days 6, 11,
and 14 postinoculation or just prior to sacrifice. Accord-
ing to TSRI Animal Resource Committee requirements,
mice had to be sacrificed when they were overtly clini-
cally ill. At the time of sacrifice (days 10 to 15 for mori-
bund mice), in addition to body weight, blood was ob-
tained to determine glucose levels by a ChemStrip and
AccuChekIII monitor and pituitary glands were removed
and placed in OTC compound 4583 (TissueTek, Sakura
TissueTek, Torrence, CA) or on some occasions not
placed in OTC. Pituitaries were then snap-frozen in liquid
nitrogen and stored at 270°C until use (Oldstone et al.,
1985, 1984a, 1982; Teng et al., 1996; Tishon and Old-
stone, 1990). All other mice (healthy) were sacrificed at
15 days post viral inoculation with similar determinations
made. The level of infectious virus in the blood was
measured by plaque assay in Vero cells (Cao et al., 1998;
Oldstone et al., 1985; Sevilla et al., 2000; Teng et al.,
1996). Studies were performed on 134 F2 mice, of which
101 had microsatellite sequencing, as well as 18 F1 mice
and groups of 10 C3H/St and 10 BALB/W mice.
Virus
The origin, passage history, and sequence of LCMV
ARM have been recorded (Oldstone et al., 1985; Salvato
et al., 1988; Tishon and Oldstone, 1990).
Localization of LCMV antigens and GH in pituitaries
Pituitaries were cut to 5 mm on a cryomicrotome and
sections were mounted on glass, fixed stepwise in 95%
ethanol:absolute ether (volume 1:1)/95% ethanol, washed
in PBS, and stained either with monoclonal antibody
LCMV ARM NP (MoAb 113) and monospecific affinity
purified antibody to mouse IgG conjugated to fluorescein
isothiocyanate (FITC) or to rhodamine, or with a monkey
antibody to mouse GH followed by a sheep antibody to
human IgG conjugated to FITC (Oldstone et al., 1985).
hemical analysis
The quantities of GH present in individual pituitary
lands were initially determined by our published proce-
ure (Oldstone et al., 1985). Thereafter we used the
assay as published by Parlow (Groesbeck and Parlow,
1987; He et al., 1998) after determining that GH levels
were equivalent in pituitaries obtained from control
4-week-old mice homogenized in buffer and stored at
270°C (pituitary GH mg/ml 46 6 6) when compared to
ituitaries initially placed in OTC compound, snap-frozen,
nd later homogenized in buffer (56 6 2) (N for each
group 5 4).
Microsatellite mapping of the host genomeDNA was obtained from tails of individual mice using
standard procedures (Oldstone et al., 1991). PCR ampli-
dfications were performed with an annealing temperature
of 55°C, as described previously (Montagutelli et al.,
1991). The sequences of the PCR primers have been
described by Dietrich et al. (1994) and are available at
http://www.genome.wi.mit.edu/cgi-bin/mouse/index.
Map distances were calculated from recombination fre-
quencies using the Map-Manager program (Manly,
1993). One hundred one mice were used to calculate
genetic distances. To account for the deviation of weight
from the Laplace–Gauss distribution, an empirical distri-
bution was obtained by a Monte Carlo method (data not
shown). The F distribution was evaluated in two simula-
tions of 20,000 random replicates, each under the as-
sumption of no linkage between the genotype and the
phenotype. For these simulations, the weights were
those observed in the experiment, and the genotypes
were randomly assigned to the members of the F2 cross.
The simulated distribution was very close to the F dis-
tribution of the table used during the remainder of this
study. For each locus, the mean and standard error of the
mean of the weight were calculated for heterozygotes
and each of the two homozygotes. Analysis of variance
was performed using the StatView program. An analysis
with Mapmaker/QTL, a program that uses a maximum
likelihood algorithm with “interval mapping” and “simul-
taneous search,” permitted better localization of the loci
and exclusion mapping (Lander et al., 1987). The dis-
tance chosen was defined by the function of Kosambi
(Davies et al., 1995).
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